FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890157064> ?p ?o ?g. }

• W2890157064 endingPage "688" @default.
• W2890157064 startingPage "683" @default.
• W2890157064 abstract "Blood transfusion safety has been increasingly improving during the past two decades. However, threats from both known and emerging pathogens require continual improvement and re-assessment of blood safety measures. In this respect, we are currently witnessing the broader implementation of Pathogen reduction technology (PRT) for blood complements. These methods, combined with existing safety measures, have helped to reduce the pathogen risks of transfusion-transmitted infections. Currently multiple reviews have compared levels of inactivation between different commercialized PRTs. However, to analyze levels of pathogen inactivation, it is necessary to understand the dynamics of infectivity as well as the modes of disease transmission by blood transfusion for various pathogens. It is well known that contributing variables include donor characteristics through the processing of blood components to ultimately the recipient characteristics, which create enormous variability in overall outcomes relative to disease transmission. The aim of this paper is to discuss bacterial and viral contamination of blood components in order to determine adequate levels of efficacy and subsequent disease transmission safety of current pathogen inactivation protocols that are designed to reduce the risk of transfusion-transmitted infections. In such a conceptual analysis, however, it is important to understand several contributing factors including the measurement of pathogen load in blood products and the dynamics, infectivity and disease transmission of various pathogens via transfusion of blood components and products. In many cases, the log reduction values observed do not truly reflect the extent of reduction in the levels of infectivity that are observed clinically. Results from clinical trials and hemovigilance programs upon routine implementation of PRT methods provide a more direct insight into effectiveness with regard to clinical relevance of in vitro spiking studies. These issues are briefly addressed in this manuscript." @default.
• W2890157064 created "2018-09-27" @default.
• W2890157064 creator A5028188209 @default.
• W2890157064 creator A5034588726 @default.
• W2890157064 creator A5051037168 @default.
• W2890157064 creator A5056842803 @default.
• W2890157064 date "2018-10-01" @default.
• W2890157064 modified "2023-09-27" @default.
• W2890157064 title "Reflections on the dynamics of bacterial and viral contamination of blood components and the levels of efficacy for pathogen inactivation processes" @default.
• W2890157064 cites W1573443302 @default.
• W2890157064 cites W1612627443 @default.
• W2890157064 cites W1861147991 @default.
• W2890157064 cites W1977537182 @default.
• W2890157064 cites W1981699986 @default.
• W2890157064 cites W1990847378 @default.
• W2890157064 cites W2021762717 @default.
• W2890157064 cites W2035722382 @default.
• W2890157064 cites W2038347882 @default.
• W2890157064 cites W2039171607 @default.
• W2890157064 cites W2043974952 @default.
• W2890157064 cites W2075002476 @default.
• W2890157064 cites W2086569072 @default.
• W2890157064 cites W2087396647 @default.
• W2890157064 cites W2104840918 @default.
• W2890157064 cites W2114315172 @default.
• W2890157064 cites W2116273381 @default.
• W2890157064 cites W2122249084 @default.
• W2890157064 cites W2122923345 @default.
• W2890157064 cites W2135796724 @default.
• W2890157064 cites W2150602209 @default.
• W2890157064 cites W2156847273 @default.
• W2890157064 cites W2170747836 @default.
• W2890157064 cites W2256083764 @default.
• W2890157064 cites W2273993300 @default.
• W2890157064 cites W2336594936 @default.
• W2890157064 cites W2398399538 @default.
• W2890157064 cites W2517528886 @default.
• W2890157064 cites W2583367536 @default.
• W2890157064 cites W2613445903 @default.
• W2890157064 cites W2616620644 @default.
• W2890157064 cites W2955652692 @default.
• W2890157064 cites W4235787402 @default.
• W2890157064 cites W4255007839 @default.
• W2890157064 doi "https://doi.org/10.1016/j.transci.2018.09.004" @default.
• W2890157064 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30220450" @default.
• W2890157064 hasPublicationYear "2018" @default.
• W2890157064 type Work @default.
• W2890157064 sameAs 2890157064 @default.
• W2890157064 citedByCount "8" @default.
• W2890157064 countsByYear W28901570642019 @default.
• W2890157064 countsByYear W28901570642020 @default.
• W2890157064 countsByYear W28901570642021 @default.
• W2890157064 countsByYear W28901570642023 @default.
• W2890157064 crossrefType "journal-article" @default.
• W2890157064 hasAuthorship W2890157064A5028188209 @default.
• W2890157064 hasAuthorship W2890157064A5034588726 @default.
• W2890157064 hasAuthorship W2890157064A5051037168 @default.
• W2890157064 hasAuthorship W2890157064A5056842803 @default.
• W2890157064 hasConcept C106358424 @default.
• W2890157064 hasConcept C126322002 @default.
• W2890157064 hasConcept C177713679 @default.
• W2890157064 hasConcept C203014093 @default.
• W2890157064 hasConcept C2522874641 @default.
• W2890157064 hasConcept C2776460866 @default.
• W2890157064 hasConcept C2779134260 @default.
• W2890157064 hasConcept C2780014101 @default.
• W2890157064 hasConcept C41008148 @default.
• W2890157064 hasConcept C71924100 @default.
• W2890157064 hasConcept C761482 @default.
• W2890157064 hasConcept C76155785 @default.
• W2890157064 hasConceptScore W2890157064C106358424 @default.
• W2890157064 hasConceptScore W2890157064C126322002 @default.
• W2890157064 hasConceptScore W2890157064C177713679 @default.
• W2890157064 hasConceptScore W2890157064C203014093 @default.
• W2890157064 hasConceptScore W2890157064C2522874641 @default.
• W2890157064 hasConceptScore W2890157064C2776460866 @default.
• W2890157064 hasConceptScore W2890157064C2779134260 @default.
• W2890157064 hasConceptScore W2890157064C2780014101 @default.
• W2890157064 hasConceptScore W2890157064C41008148 @default.
• W2890157064 hasConceptScore W2890157064C71924100 @default.
• W2890157064 hasConceptScore W2890157064C761482 @default.
• W2890157064 hasConceptScore W2890157064C76155785 @default.
• W2890157064 hasIssue "5" @default.
• W2890157064 hasLocation W28901570641 @default.
• W2890157064 hasLocation W28901570642 @default.
• W2890157064 hasOpenAccess W2890157064 @default.
• W2890157064 hasPrimaryLocation W28901570641 @default.
• W2890157064 hasRelatedWork W1989515713 @default.
• W2890157064 hasRelatedWork W1993985716 @default.
• W2890157064 hasRelatedWork W1995835484 @default.
• W2890157064 hasRelatedWork W2007134309 @default.
• W2890157064 hasRelatedWork W2755638713 @default.
• W2890157064 hasRelatedWork W2890157064 @default.
• W2890157064 hasRelatedWork W2952376762 @default.
• W2890157064 hasRelatedWork W3208072607 @default.
• W2890157064 hasRelatedWork W4205333513 @default.
• W2890157064 hasRelatedWork W4306878498 @default.
• W2890157064 hasVolume "57" @default.

• next